According to the latest report published by Credence Research, Inc. “Non-Invasive Prenatal Testing Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the non-invasive prenatal testing market was valued at USD 613.0 Mn in 2015, and is expected to reach USD 1,939.9 Mn by 2022, expanding at a CAGR of 17.9% from 2016 to 2022.
Browse the full report Non-Invasive Prenatal Testing: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/non-invasive-prenatal-testing-market
The global non-invasive prenatal tests (NIPT) market is experiencing a double-digit growth facilitated by market drivers such as rise in average maternity age, growing incidence of chromosomal abnormalities that demand early and non-invasive detection. Other major factor that aids to the growth of this market is rise in healthcare expenditure.
Non-invasive prenatal testing is defined as a highly sensitive screening process that assists in detecting chromosomal abnormalities in the fetus during pregnancy. Some of such chromosomal abnormal abilities that can be detected through NIPT are Down syndrome, Patau syndrome, Edwards’ syndrome and Turner syndrome.
Among the available NIPT tests, the MaternitT21 test is the largest segment and it is anticipated that its dominance will continue through 2022. It was the first test to receive approval for detection of Trisomy 21 in 2011. Other chromosomal abnormalities that could be detected with MaternitT21 are Wolf-Hirschhorn syndrome, DiGeorge syndrome, Langer-Giedion syndrome, 1q36 deletion syndrome and Jaconsen syndrome. MaterniT21 used cfDNA and parallel sequencing technology and delivers results in a 5 day period.
Browse the full report at http://www.credenceresearch.com/report/non-invasive-prenatal-testing-market
North America is the largest market for non-invasive prenatal testing. Emerging markets of Asia-Pacific and Latin America are growing at a significant growth rate, attributed by the growing awareness about chromosomal abnormalities, their prevention, growing population of late maternity age, and rapid development of healthcare infrastructure. However, ethical concerns associated with such tests is the most prominent market restraint.
The major players engaged in the global noninvasive prenatal testing market are LifeCodexx AG, Illumina, Inc., Sequenom, Inc. LABCORP, Natera, Inc. and others.
Drug of Abuse Testing / Screening Market By Test Type (Urine Drug Tests, Oral Fluid Drug Tests, Hair Drug Tests, Blood Drug Tests, Other Drug Tests), Location (On-site Screening, Laboratory-based Screening) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022
Direct-to-Consumer Genetic Testing Market By Channel (Direct sales, Retail sales, Doctors office), Business Model (Genome data bank material model, Individual health planning model, Comprehensive genome tests model, Medical precision tests model, Restricted trait tests model) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022
Liquid Biopsy Market By Analytes (Circulating Tumor Cells (CTCs), Circulating Tumor Dna (CtDNA), Extracellular Vesicles (EVs)), By Application (Prognosis, Diagnosis, Therapy Monitoring) – Market Growth, Future Prospects and Competitive Analysis, 2016-2022
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Name: Chris Smith
Designation: Global Sales Manager
Web: Credence Research
Release ID: 4029